Special report: laboratory testing to allow area under the curve (AUC)-targeted 5-fluorouracil dosing for patients administered chemotherapy for cancer.
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000097:blood / Q000633:toxicity; D019540:Area Under Curve; D017024:Chemotherapy, Adjuvant / Q000379:methods*; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004354:Drug Screening Assays, Antitumor / Q000379:methods; D005472:Fluorouracil / Q000008:administration & dosage* / Q000097:blood / Q000633:toxicity; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic
D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil